Interventional Neurology Devices

Interventional Neurology Devices

Global Interventional Neurology Devices Market to Reach US$4.9 Billion by 2030

The global market for Interventional Neurology Devices estimated at US$3.6 Billion in the year 2023, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Cerebral Embolization & Aneurysm Coiling Device, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Cerebral Angioplasty & Stenting Systems segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$974.3 Million While China is Forecast to Grow at 4.3% CAGR

The Interventional Neurology Devices market in the U.S. is estimated at US$974.3 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$773.6 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Interventional Neurology Devices Market - Key Trends & Drivers Summarized

What Are Interventional Neurology Devices and Why Are They Crucial in Treating Neurovascular Disorders?

Interventional neurology devices are specialized medical instruments used in the minimally invasive treatment of neurovascular disorders, such as strokes, aneurysms, and arteriovenous malformations (AVMs). These devices include catheters, stents, embolization coils, and clot retrieval systems, which are designed to navigate the intricate and delicate vasculature of the brain. Interventional neurology has become a crucial field in modern medicine, as it offers patients less invasive alternatives to traditional open surgeries, leading to faster recovery times, reduced risk of complications, and improved outcomes. As the prevalence of neurovascular disorders continues to rise globally, the demand for advanced interventional neurology devices is increasing, making them essential tools in the treatment and management of these life-threatening conditions.

How Are Technological Advancements Shaping the Interventional Neurology Devices Market?

Technological advancements are significantly shaping the interventional neurology devices market, particularly through innovations in imaging, catheter design, and materials science. Advances in imaging technologies, such as high-resolution 3D angiography and real-time intraoperative imaging, are enhancing the precision and safety of neurovascular procedures by providing detailed visualization of the brain’s vasculature. The development of more flexible and steerable catheters is improving the ability of interventionalists to navigate complex arterial pathways, reducing the risk of vessel injury and improving procedural success rates. Innovations in materials science, including the use of biocompatible and radiopaque materials, are enhancing the safety and efficacy of devices such as stents and embolization coils, making them more effective in treating complex neurovascular conditions. These technological trends are driving the adoption of interventional neurology devices across healthcare settings, as they enable more effective and less invasive treatment options for patients with neurovascular disorders.

Why Is There an Increasing Demand for Interventional Neurology Devices in Healthcare?

The demand for interventional neurology devices is increasing in healthcare due to the growing prevalence of neurovascular disorders, the aging population, and the rising adoption of minimally invasive procedures. Stroke remains a leading cause of death and disability worldwide, driving the need for effective treatment options such as thrombectomy devices and embolization coils. The aging population is also contributing to the demand for interventional neurology devices, as older adults are at higher risk for conditions such as aneurysms and AVMs that require advanced interventional treatment. The trend towards minimally invasive procedures is further fueling demand, as patients and healthcare providers seek alternatives to open surgeries that offer faster recovery times, reduced hospital stays, and lower complication rates. Additionally, the increasing availability of specialized training for interventional neurologists and the expansion of stroke centers are enhancing the adoption of these devices, as more healthcare facilities are equipped to perform complex neurovascular procedures. As the burden of neurovascular diseases continues to grow, the demand for interventional neurology devices is expected to increase.

What Factors Are Driving the Growth in the Interventional Neurology Devices Market?

The growth in the interventional neurology devices market is driven by several factors related to technological advancements, demographic trends, and the increasing focus on minimally invasive treatments. One of the primary drivers is the rising prevalence of neurovascular disorders, such as strokes and aneurysms, which require advanced interventional devices for effective treatment. The aging global population is also a significant growth factor, as older adults are more susceptible to neurovascular conditions that necessitate interventional care. The growing preference for minimally invasive procedures is further propelling the market, as these techniques offer numerous benefits over traditional open surgeries, including faster recovery and reduced risk of complications. Technological advancements in imaging, catheter design, and materials are also driving market growth by improving the safety, efficacy, and accessibility of interventional neurology procedures. Additionally, the increasing investment in healthcare infrastructure and the expansion of specialized stroke centers are creating new opportunities for the adoption of interventional neurology devices. As these factors continue to influence the healthcare landscape, the interventional neurology devices market is expected to experience sustained growth, driven by the need for advanced, effective, and minimally invasive treatment options for neurovascular disorders.

Select Competitors (Total 43 Featured) -

• Abbott Laboratories
• ACANDIS GmbH
• B. Braun Melsungen AG
• Bayer AG
• Biosensors International Group Ltd.
• Boston Scientific Corporation
• DePuy Synthes
• evonos GmbH & Co. KG
• Medtronic, Inc.
• Merit Medical Systems, Inc.
• MicroPort Scientific Corporation
• Penumbra, Inc.
• Stryker Corporation
• Surtex Instruments
• Terumo Corporation
• W. L. Gore & Associates, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.